SAO PAULO, Jan 13 (Reuters) – Brazilian President Jair Bolsonaro said on Wednesday he was right to criticize the credibility of a Chinese COVID-19 vaccine developed by Sinovac Biotech that posted disappointing efficacy results in local trials.
On Tuesday, researchers in Sao Paulo state announced that the Chinese vaccine was 50.4% effective at preventing symptomatic infections in a local trial – barely enough for regulatory approval and well below the rate announced last week.…
The post Brazil's Bolsonaro says he was right to question Chinese COVID-19 vaccine appeared first on ChinaPulse.com.